Please provide your email address to receive an email when new articles are posted on . “Measuring serum follicle-stimulating hormone (FSH) in women in their late 40s may help us forecast who will ...

For women approaching menopause, a number of changes begin to occur. One of the most common is an increase in obesity, which, in turn, raises the risk for breast cancer after menopause. That much is ...

The synthesis of follicle-stimulating hormone (FSH) in pituitary gonadotrope cells is a tightly controlled process that integrates multiple endocrine and paracrine signals. Central to this regulation ...

Please provide your email address to receive an email when new articles are posted on . Women with polycystic ovary syndrome have less increase in follicle-stimulating hormone after triptorelin ...

Extract: The concerntration of serum luteinizing hormone (LH) and follicle stimulating hormone (FSH) was determined using a double antibody radioimmunoassay in 129 normal girls. Of theis group, 48 ...

Follicle-stimulating hormone receptor (FSHR) N680S–genotyped women treated with either recombinant FSH or urinary FSH had higher pregnancy rates of 51% vs 40% in non-genotyped control individuals.

Phase 2 trial of trastuzumab and/or everolimus in hormone-resistant HER2-negative metastatic breast cancer. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not ...

Diminished bone density is common among menopausal women and raises their risk of osteoporosis, bone fractures and subsequent complications. Research has traditionally focused on therapies that seek ...